Our laboratory has shown that myeloid-ILK-deficient cells in an experimental colitis model exhibited reduced activation of NF-κB and PI3K signaling pathway, but elevated STAT3 activation and proliferation of intestinal epithelium (Ahmed et al., 2017). The gene discussed is ILK; the disease is colitis.